Sign in Subscribe
Vaccines

CEOs of Nine Pharmaceutical Companies Pledge to Prioritize Safety in COVID-19 Vaccine Development

Strategic Insights

— 1 min read

Top executives from AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi have signed a historic pledge to ensure the safety and well-being of individuals vaccinated against COVID-19. The commitment comes as these companies work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.

The pledge emphasizes the importance of adhering to high ethical standards and sound scientific principles in vaccine development. The companies agree to prioritize the safety and well-being of vaccinated individuals, continue to adhere to high scientific and ethical standards in clinical trials, and ensure a sufficient supply and range of vaccine options.

Key Takeaways:

  • Nine pharmaceutical companies, including AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi, have signed a pledge to prioritize the safety of COVID-19 vaccine development.
  • The companies have agreed to adhere to high scientific and ethical standards in clinical trials and ensure a sufficient supply and range of vaccine options.
  • These companies have collectively developed more than 70 novel vaccines that have helped eradicate complex and deadly public health threats.
  • The pledge emphasizes the importance of expert regulatory authorities' guidance, such as the FDA's, in the development of COVID-19 vaccines.
  • Companies will work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.

Statistics:

  • 9 pharmaceutical companies have signed the pledge
  • More than 70 novel vaccines have been developed by these companies in collaboration
  • The FDA has established clear guidance for the development of COVID-19 vaccines
  • The FDA requires large, high-quality clinical trials with randomization and blinding, as well as significant numbers of participants across diverse populations
  • Assembly of sufficient vaccine supply is a commitment made by pharmaceutical companies

Sources:

  • BioNTech SE
  • AstraZeneca
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi

Read more